|
Bio Asia, Asia's premier life sciences and health tech forum, has a line-up of inspirational speakers and industry luminaries to ignite a discussion with participating leaders, MSMEs and start-ups to inspire and make India an undisputed leader in the life sciences space. With the impressive line-up of speakers, Bio Asia 2025 is all set to act as a ‘Catalyst of Change’ driving rapid transformation in the life sciences space.
With India emerging as a key player in global healthcare and biotechnology, Bio Asia 2025 will provide an unparalleled platform for collaborations, knowledge sharing, and investment opportunities. The event will continue to strengthen Hyderabad’s position as a hub for life sciences innovation, reinforcing its contribution to the global healthcare ecosystem.
Bio Asia 2025 will feature high-impact sessions, panel discussions, and networking opportunities, engaging thought leaders, policymakers, and innovators to explore solutions for global healthcare challenges. The event will also highlight cutting-edge advancements in AI-driven healthcare, clinical research, and personalized medicine.
A power packed agenda comprising of address from A Revanth Reddy, CM of Telangana, Dr. Jeannette Young, Governor of Queensland, Amitabh Kant, G20 Sherpa, Piyush Goyal, Union minister of industry, besides the global industry leaders will be the highlight of Bio Asia 2025.
Notable industry leaders from the leading global organizations like Robert A. Bradway (chairman & CEO, Amgen), Prof. Patrick Tan, (executive director, Genome Institute of Singapore), Dr. Ken Washington (CTO, Medtronic), Dr. Boris Stoffel (managing director, Miltenyi Biotec) along with leaders from other global healthcare organizations will participate across 8 sessions scheduled on 25th and 26th February 2025.
The CEO Conclave scheduled on 25th February 2025 will have eminent speakers Dr S Somanath, former chairman, ISRO, Satish Reddy, chairman, Dr Reddy’s Laboratories, Dr Krishna Ella, chairman and managing director, Bharat Biotech International Ltd, Dr Satyanarayana Chava, founder and CEO, Laurus Labs, Cesar Concepcion, chief commercial officer, APMA region, Novartis and Winselow Tucker, president and general manager, Lilly India who will discuss the key opportunities and challenges for the life sciences in Indian and overseas markets and the disruptive role India can adopt to lead the global life sciences space with emerging technology innovations.
BioAsia 2025 is set to be a landmark event for the life sciences and healthcare industry. As a hub for global healthcare innovations, Telangana has become a key player in driving medical research, biotechnology, and pharmaceutical excellence. BioAsia will continue its tradition of showcasing Telangana's leadership in fostering industry growth, collaboration, and cutting-edge research while positioning the state as a key destination for global life sciences investments.
|